ATE490469T1 - Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden - Google Patents

Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden

Info

Publication number
ATE490469T1
ATE490469T1 AT04748820T AT04748820T ATE490469T1 AT E490469 T1 ATE490469 T1 AT E490469T1 AT 04748820 T AT04748820 T AT 04748820T AT 04748820 T AT04748820 T AT 04748820T AT E490469 T1 ATE490469 T1 AT E490469T1
Authority
AT
Austria
Prior art keywords
growth
cnp
plasma
assessment
provides
Prior art date
Application number
AT04748820T
Other languages
English (en)
Inventor
Timothy Charles Ramsey Prickett
Eric Arnold Espiner
Arthur Mark Richards
Timothy Grant Yandle
Michael Gary Nicholls
Original Assignee
Otago Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Application granted granted Critical
Publication of ATE490469T1 publication Critical patent/ATE490469T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT04748820T 2003-06-17 2004-06-17 Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden ATE490469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ52652603 2003-06-17
PCT/NZ2004/000125 WO2004111653A1 (en) 2003-06-17 2004-06-17 Assessment of skeletal growth using measurements of nt-cnp peptides

Publications (1)

Publication Number Publication Date
ATE490469T1 true ATE490469T1 (de) 2010-12-15

Family

ID=33550523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748820T ATE490469T1 (de) 2003-06-17 2004-06-17 Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden

Country Status (7)

Country Link
US (1) US7919255B2 (de)
EP (1) EP1644740B1 (de)
AT (1) ATE490469T1 (de)
CA (1) CA2570398C (de)
DE (1) DE602004030342D1 (de)
DK (1) DK1644740T3 (de)
WO (1) WO2004111653A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070037208A1 (en) * 2003-05-29 2007-02-15 Foote Robert S Method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
CA2559228C (en) 2004-04-21 2016-06-21 Enobia Pharma Inc. Bone delivery conjugates and method of using same to target proteins to bone
US7767404B2 (en) * 2005-08-16 2010-08-03 Chipotle Business Group, Inc. Apparatus and method for single-step immunosorbent assay for single and multiple analytes
US8735142B2 (en) * 2005-08-16 2014-05-27 Chipotle Business Group, Inc. Systems and methods for immunosorbent assays for single and multiple analytes
PT2432489T (pt) * 2009-05-20 2016-12-07 Biomarin Pharm Inc Variantes do péptido natriurético de tipo c
WO2012088608A1 (en) 2010-12-27 2012-07-05 Enobia Canada Limited Partnership Compositions comprising natriuretic peptides and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
IN2015KN00571A (de) * 2012-08-13 2015-07-17 Otago Innovation Ltd
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
MX389350B (es) 2014-12-05 2025-03-19 Alexion Pharma Inc Fosfatasas alcalinas recombinantes y usos de las mismas para el tratamiento de convulsiones.
JP6868561B2 (ja) 2015-01-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼ欠損を有する被験者を治療する方法
CN108350440A (zh) 2015-08-17 2018-07-31 阿雷克森制药公司 碱性磷酸酯的制造
JP6868617B2 (ja) 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ， インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ（ｔｎｓａｌｐ）酵素補充療法に有効な投薬計画の特定
JP2018533571A (ja) 2015-10-30 2018-11-15 アレクシオン ファーマシューティカルズ， インコーポレイテッド 患者の頭蓋縫合早期癒合症を治療するための方法
WO2017155569A1 (en) 2016-03-08 2017-09-14 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
JP7613826B2 (ja) 2016-04-01 2025-01-15 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼによって筋力低下を治療すること
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
WO2017218911A1 (en) 2016-06-17 2017-12-21 Abbott Laboratories BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
EP3500289B1 (de) 2016-08-18 2024-10-09 Alexion Pharmaceuticals, Inc. Asfotase alfa zur behandlung von tracheobronchomalazie
EP3600383A4 (de) 2017-03-31 2020-10-28 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von hypophosphatasie (hpp) bei erwachsenen und jugendlichen
US11913039B2 (en) 2018-03-30 2024-02-27 Alexion Pharmaceuticals, Inc. Method for producing recombinant alkaline phosphatase
US12268733B2 (en) 2018-08-10 2025-04-08 Alexion Pharmaceuticals, Inc. Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
CA3161266A1 (en) 2019-12-09 2021-06-17 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
AU2021337652B2 (en) 2020-09-04 2025-01-30 Alexion Pharmaceuticals, Inc. Methods for treating bone mineralization disorders
BR112023016048A2 (pt) 2021-02-12 2023-11-14 Alexion Pharma Inc Polipeptídeos de fosfatase alcalina e métodos de uso dos mesmos
CN119619532A (zh) * 2024-10-30 2025-03-14 中国科学院动物研究所 一种用于评价和/或预测骨骼发育状况的试剂盒和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407580B (de) * 1999-08-20 2001-04-25 Biomedica Gmbh Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use

Also Published As

Publication number Publication date
US7919255B2 (en) 2011-04-05
EP1644740A4 (de) 2007-12-12
EP1644740B1 (de) 2010-12-01
DE602004030342D1 (de) 2011-01-13
CA2570398C (en) 2020-05-12
DK1644740T3 (da) 2011-02-21
CA2570398A1 (en) 2004-12-23
US20070292966A1 (en) 2007-12-20
EP1644740A1 (de) 2006-04-12
WO2004111653A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
ATE490469T1 (de) Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
KR101256133B1 (ko) 전기화학적 분석대상물 검출 동안에 비정상적인 경로의검출을 위한 방법 및 장치
Yetley et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary
Hosoi et al. Quantitative analysis of calcium-dependent vesicle recruitment and its functional role at the calyx of Held synapse
Sargent et al. Rapid vesicular release, quantal variability, and spillover contribute to the precision and reliability of transmission at a glomerular synapse
Shetty et al. Developmental validation of a point-of-care, salivary α-amylase biosensor
CA2535833A1 (en) Method and apparatus for assay of electrochemical properties
EP2042865A3 (de) Systeme und Verfahren zur Unterscheidung zwischen einer Kontrolllösung und einer physiologischen Probe
CY1117095T1 (el) Συσκευη και μεθοδος για ηλεκτροχημικη ανιχνευση
Kang et al. Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine
ATE509275T1 (de) Schnelltest für glykiertes albumin
WO2010127169A3 (en) Performance reports associated with continuous sensor data from multiple analysis time periods
BRPI0309503A8 (pt) Fitas de teste, métodos de produção e uso de pluralidade de fitas de teste, de medição de glicose em amostra de sangue e de identificação de fita, dispositivo de armazenamento de dados removível para medidor e medidores
EP1359417A3 (de) Vorrichtung und Methode zur Bestimmung einer Analytkonzentration
MX2010000971A (es) Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
MXPA02010106A (es) Determinacion de suficiencia de volumen de muestra en dispositivos biosensores.
TW200413718A (en) Method and system for determining the acceptability of signal data collected from a prothrombin time test strip
RU2010128653A (ru) Компенсация на основе наклона
JP2000275163A5 (ja) 粒子分析装置および自動粒子分析方法
KR20130066841A (ko) 당화혈색소 센서스트립, 당화혈색소 측정장치 및 이를 이용한 당화혈색소 측정방법
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
NZ547986A (en) Method and apparatus for monitoring cardiac health with feed-back to the patient depending on test results
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
US20150153298A1 (en) Method of Measuring Hematocrit (HCT), and Measurement Device Using the Method
WO2004093784A3 (en) Systems and methods for blood glucose sensing

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties